Lantheus Holdings, Inc. Increase (Decrease) in Other Operating Assets
Lantheus Holdings, Inc. (LNTH) reported Increase (Decrease) in Other Operating Assets of -$4.84 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2026-08-06
- Lantheus Holdings, Inc. increase (decrease) in other operating assets for the quarter ending 2026-06-30 was -$5.09M, a 466.57% decline year-over-year.
- Lantheus Holdings, Inc. increase (decrease) in other operating assets for the quarter ending 2026-03-31 was $244.00K, a 53.79% decline year-over-year.
- Lantheus Holdings, Inc. increase (decrease) in other operating assets for the quarter ending 2025-12-31 was -$938.00K.
- Lantheus Holdings, Inc. increase (decrease) in other operating assets for the quarter ending 2025-09-30 was $4.43M, a 199.59% increase year-over-year.
- Lantheus Holdings, Inc. increase (decrease) in other operating assets for fiscal 2025 was $5.41M.
- Lantheus Holdings, Inc. increase (decrease) in other operating assets for fiscal 2024 was -$4.44M, a 283.62% decline from fiscal 2023.
- Lantheus Holdings, Inc. increase (decrease) in other operating assets for fiscal 2023 was $2.42M.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$5.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$4.84M 10-Q · filed 2026-08-06 | -$5.78M derived: sum of 3 quarters · filed 2026-08-06 | -$1.35M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $244.00K 10-Q · filed 2026-05-07 | -$694.00K derived: sum of 2 quarters · filed 2026-05-07 | $3.73M derived: sum of 3 quarters · filed 2026-05-07 | $5.12M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$938.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.49M derived: sum of 2 quarters · filed 2026-02-26 | $4.88M derived: sum of 3 quarters · filed 2026-08-06 | $5.41M 10-K · filed 2026-02-26 |
| 2025-09-30 | $4.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $5.82M derived: sum of 2 quarters · filed 2026-08-06 | $6.34M 10-Q · filed 2025-11-06 | $3.24M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $1.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $1.92M 10-Q · filed 2026-08-06 | -$1.19M derived: sum of 3 quarters · filed 2026-08-06 | $289.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $528.00K 10-Q · filed 2026-05-07 | -$2.58M derived: sum of 2 quarters · filed 2026-05-07 | -$1.10M derived: sum of 3 quarters · filed 2026-05-07 | |
| 2024-12-31 | -$3.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$1.63M derived: sum of 2 quarters · filed 2026-02-26 | -$4.44M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $1.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$1.33M 10-Q · filed 2025-11-06 | ||
| 2024-06-30 | -$2.81M 10-Q · filed 2025-08-06 | |||
| 2023-12-31 | $2.42M 10-K · filed 2026-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |